Recall
FDAHealthApril 1, 2026

Wells Pharma of Houston LLC — fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.

⚠️ cGMP deviations.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
April 1, 2026

U.S. Nationwide.

What's affected?

Product
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.
Lot code
022326203650432

Additional details

Lot 022326203650432; Exp Date 06/25/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 150 syringes.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.